{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:29:03Z","timestamp":1768595343287,"version":"3.49.0"},"reference-count":21,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/14712598.2025.2606897","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T08:31:09Z","timestamp":1766046669000},"page":"1353-1358","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Ranibizumab biosimilar (Oceva) \u2013 real-world experience from India (RORE study)"],"prefix":"10.1080","volume":"25","author":[{"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[{"name":"Lotus Eye Hospital and Institute","place":["Coimbatore, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Sheth","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Eye Institute","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitaranjan","family":"Mishra","sequence":"additional","affiliation":[{"name":"Trilochan Netralaya","place":["Sambalpur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debdulal","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Disha Eye Hosiptal","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagyashree","family":"Meshram","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Eye Institute","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somy","family":"Purohit","sequence":"additional","affiliation":[{"name":"Trilochan Netralaya","place":["Sambalpur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"International Retina Biosimilar Study Group (Inter BIOS Group)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01554-2"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1866_19"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003626"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.11.017"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0722-6"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2176218"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0636-3"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02117-z"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03284-x"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2025.2506445"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101358"},{"key":"e_1_3_7_13_1","first-page":"247412642513222","article-title":"Biosimilar ranibizumab (Ranieyes) safety and efficacy in the real world: BRESER study","volume":"27","author":"Sharma A","year":"2025","unstructured":"Sharma A, Holz FG, Kumar N, et al. Biosimilar ranibizumab (Ranieyes) safety and efficacy in the real world: BRESER study. J Vitreoretin Dis. 2025;27:24741264251322213.","journal-title":"J Vitreoretin Dis"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03220-z"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000488602"},{"issue":"2","key":"e_1_3_7_16_1","first-page":"368","article-title":"Real life clinical effectiveness of Razumab\u00ae (world\u2019s first biosimilar ranibizumab) in wet age-related macular degeneration: a subgroup analysis of pooled retrospective RE-ENACT study","volume":"6","author":"Sharma S","year":"2018","unstructured":"Sharma S, Khan MA, Chaturvedi A, et al. Real life clinical effectiveness of Razumab\u00ae (world\u2019s first biosimilar ranibizumab) in wet age-related macular degeneration: a subgroup analysis of pooled retrospective RE-ENACT study. Int J Oph Thalmol Eye Res. 2018;6(2):368\u2013373.","journal-title":"Int J Oph Thalmol Eye Res"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0434-y"},{"key":"e_1_3_7_18_1","unstructured":"FDA rejects first DARPin. [cited 2025 Aug 11]. Available from: https:\/\/www.nature.com\/articles\/d41573-020-00127-8"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0853-9"},{"key":"e_1_3_7_20_1","unstructured":"ASRS reports six cases of occlusive retinal vasculitis linked to pegcetacoplan injection. [cited 2025 Aug 11]. Available from: https:\/\/www.ophthalmologytimes.com\/view\/asrs-reports-six-cases-of-occlusive-retinal-vasculitis-linked-to-pegcetacoplan-injection"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/24741264231202080"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0745-z"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2025.2606897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:11:03Z","timestamp":1767150663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2025.2606897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/14712598.2025.2606897"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2025.2606897","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}